US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist
  • 1.410
  • +0.080+6.02%
Close May 10 16:00 ET
  • 1.370
  • -0.040-2.84%
Post 19:59 ET
8.61MMarket Cap-13P/E (TTM)

Transcode Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Transcode Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-6.51

+97.94%
Analyst Rating

Buy

Apr 3, 2024

Transcode Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
Apr 7, 20222021/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
Apr 7, 20222021/Q40.000 / 0.000--
--------

Unlock Free Earnings Estimates

Transcode Therapeutics Earnings Reports

  • Transcode Therapeutics | 10-K: Annual report

    Apr 2 05:14

  • Transcode Therapeutics: Q3 2023 Earnings Report

    Nov 15, 2023 05:44

  • Transcode Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 15, 2023 04:31

  • Transcode Therapeutics | 10-Q: Q1 2023 Earnings Report

    May 16, 2023 04:20

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 3, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+0.22%